Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

NCT04417257 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
351
Enrollment
INDUSTRY
Sponsor class

Stopped Phase 2 completed normally, Phase 3 terminated for futility due to lack of aggravation events.

Conditions

Interventions

Sponsor

Laurent Pharmaceuticals Inc.